SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 43 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,305,408 | -59.2% | 800,000 | -55.6% | 0.00% | -75.0% |
Q3 2022 | $3,196,000 | +33.4% | 1,800,000 | -7.6% | 0.00% | +100.0% |
Q2 2022 | $2,395,000 | -12.2% | 1,948,000 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $2,728,000 | +26.1% | 1,948,000 | +26.1% | 0.00% | +100.0% |
Q4 2021 | $2,163,000 | +96.6% | 1,545,000 | +40.5% | 0.00% | 0.0% |
Q3 2021 | $1,100,000 | +120.0% | 1,100,000 | +120.0% | 0.00% | – |
Q2 2021 | $500,000 | -23.4% | 500,000 | 0.0% | 0.00% | – |
Q1 2021 | $653,000 | -53.2% | 500,000 | -12.1% | 0.00% | -100.0% |
Q4 2020 | $1,395,000 | +18.2% | 569,000 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $1,180,000 | -9.6% | 569,000 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $1,306,000 | +157.1% | 569,000 | +69.9% | 0.00% | – |
Q1 2020 | $508,000 | -40.7% | 335,000 | -23.9% | 0.00% | -100.0% |
Q4 2019 | $856,000 | +159.4% | 440,000 | +76.0% | 0.00% | – |
Q3 2019 | $330,000 | -40.6% | 250,000 | 0.0% | 0.00% | – |
Q2 2019 | $556,000 | -91.9% | 250,000 | -93.5% | 0.00% | -100.0% |
Q1 2019 | $6,902,000 | – | 3,825,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DeepCurrents Investment Group LLC | 61,662,000 | $127,669,000 | 4.30% |
WOLVERINE ASSET MANAGEMENT LLC | 94,165,000 | $195,054,000 | 1.73% |
SSI INVESTMENT MANAGEMENT LLC | 6,418,000 | $13,306,000 | 1.15% |
Opti Capital Management, LP | 3,625,000 | $7,517,000 | 0.92% |
LINDEN ADVISORS LP | 32,702,000 | $67,675,000 | 0.82% |
Verition Fund Management LLC | 14,948,000 | $31,032,000 | 0.62% |
ADVENT CAPITAL MANAGEMENT /DE/ | 11,418,000 | $23,673,000 | 0.52% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 5,000,000 | $10,382,000 | 0.40% |
AQR Arbitrage LLC | 4,625,000 | $9,602,000 | 0.35% |
Calamos Advisors LLC | 25,051,000 | $51,955,000 | 0.33% |